Cointime

Triosyn

company

About

Triosyn Corp. has developed a novel technology to kill disease-causing microorganisms and to treat microbial infections.

  • 11 - 50

Highlights

Total Funding Amount
$4M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$4M
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 1992
Number Of Employee
11 - 50
Operating Status
Active

Triosyn Corp. has developed a novel technology to kill disease-causing microorganisms and to treat microbial infections. Its core technology, Triosyn(R) resin, is an iodinated polymer that interacts with and kills all microorganisms on contact, and due to a proprietary demand-release delivery mechanism provides enhanced safety to humans and the environment. The basic formulation of Triosyn(R) has been registered with the EPA and further registration of Triosyn(R) applications are in process.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$4M
Triosyn has raised a total of $4M in funding over 2 rounds. Their latest funding was raised on Jun 2, 2003 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 2, 2003 Series Unknown $4M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Triosyn is funded by 2 investors. CDP Capital Technology Ventures and Innovatech Grand Montreal are the most recent investors.
Investor Name Lead Investor Funding Round
CDP Capital Technology Ventures — Series Unknown
Innovatech Grand Montreal — Series Unknown
Cointime
Content
Company